Skip to content

Social attention deficits in patients with depression and insomnia disorder and the underlying cognitive neural mechanisms

Social attention deficits in patients with depression and insomnia disorder and the underlying cognitive neural mechanisms

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600125089
Enrollment
Unknown
Registered
2026-05-21
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depressive disorder / depressive disorder

Interventions

Clinical group:none
Control Group:none

Sponsors

Beijing Huilongguan Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Disease Group: 1. Age 18-55 years old; 2. Meets the diagnostic criteria of the 5th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) for depressive disorders, primary insomnia, and secondary insomnia caused by depressive episodes, and confirmed by two attending psychiatrists or above; 3. Duration of insomnia >= 3 months; 4. ISI total score >= 15; 5. Education level >= 9 years, normal vision and hearing (or corrected), with normal reading and writing ability to complete scale assessments; 6. No systematic use of psychiatric medications in the past month; 7. Voluntarily participates in this study and signs written informed consent. Control Group: 1. Age 18-55 years old; 2. Matched with the disease group by age (±3 years) and same gender; 3. Education level >= 9 years; 4. Normal vision and hearing (or corrected), no color weakness or color blindness; 5. Voluntarily participates in the study and signs informed consent.

Exclusion criteria

Exclusion criteria: 1. Other mental disorders meeting DSM-5 diagnostic criteria: bipolar disorder, schizophrenia, alcohol and drug dependence, phobias, acute stress disorder, and post-traumatic stress disorder, etc.; 2. Immune and endocrine diseases, cerebrovascular diseases, tumors, severe heart, liver, kidney, and other diseases, and infectious diseases that occurred in the past two weeks; 3. Accompanied by mental retardation or other organic brain diseases, presence of organic auditory or/and visual perception disorders; IQ below 85; 4. Women who are pregnant or breastfeeding; 5. Taken psychiatric medications within the past month; 6. Received physical modulation treatments such as tDCS, tACS, TMS, or non-convulsive electroconvulsive therapy in the past 6 months; 7. Other conditions deemed by the researcher to be unsuitable for participation in this study.

Design outcomes

Primary

MeasureTime frame
Insomnia Severity Index (ISI);cueing-effect;Functional structure and functional changes of the brain;

Countries

China

Contacts

Public ContactZhang Ting

Beijing Huilongguan Hospital Affiliated to Capital Medical University

qtxzting@163.com+86 10 8302 4135

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 30, 2026